REVATIS VET
1015.868.627 · rovalta.com · 05/11/2026
REVATIS VET
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOREVATIS VET is a Private limited company incorporated in 2024. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Marche-en-Famenne.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 1015.868.627
- Incorporation
- 04/11/2024
- Legal form
- Private limited company
- Registered office
- Aye, Rue de la Science 8
6900 Marche-en-Famenne · WallonieSee on map - Contributed capital
- 595 491,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 1 filingTrend over 1 financial year
| 2025 | |
|---|---|
| Income statement | |
| Gross margin | 3,2 k € |
| EBITDA | 3,2 k € |
| Operating result | -112,1 k € |
| Net result | -112,4 k € |
| Balance sheet | |
| Equity | 483,1 k € |
| Total assets | 614,9 k € |
| Cash | 71,5 k € |
| Debts | 131,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Didier SERTEYN | Directorsince 04/11/2024 | ||
| Directorsince 04/11/2024 |
Other companies at this address
Aye, Rue de la Science 8 6900 Marche-en-Famenne| Company | CBE no. |
|---|---|
AGRICELLS● Active | 0742.991.393 |
ALEXEIA● Active | 1043.223.221 |
| 0416.914.413 | |
| 0457.901.762 | |
| 0863.356.814 | |
ATB THERAPEUTICS● Active | 0677.980.015 |
| 1031.100.991 | |
CER-Groupe● Active | 0420.654.158 |
INVESTY CORPORATE● Active | 1008.960.841 |
LivingMed Biotech● Active | 0748.443.684 |
Orgenesis (Belgium)● Bankrupt | 0540.866.555 |
ORGENESIS SERVICES SRL● Bankrupt | 0790.353.624 |
RevaTis● Active | 0541.682.642 |
| 0731.712.273 |
Financials
Full financial information
Source · NBB| 2025 | |
|---|---|
| Type of account | Micro model |
| Start of the financial year | 01/11/2024 |
| Closing of the financial year | 31/12/2025 |
| Length of the financial year | 14 months |
| Filing date | 21/07/2026 |
| General meeting | 17/06/2026 |
| Currency of the financial year | EUR |
| NBB quality label | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 1 filing| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 17/06/2026 | 21/07/2026 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Didier SERTEYN | Directorsince 04/11/2024 | ||
| Directorsince 04/11/2024 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Aye, Rue de la Science 8, 6900 Marche-en-FamenneCurrent | accounts 2025 | Accounts 2025 · 2026-00319046 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| REVATIS VETCurrent | accounts 2025 | Accounts 2025 · 2026-00319046 |
Events
- 2025Annual accounts 2025-112,4 k €
- 04/11/2024IncorporationPrivate limited company